BIOC logo

Biocept (BIOC) EBITDA

Annual EBITDA

-$30.24 M
-$29.36 M-3340.39%

December 31, 2022

Summary

Performance

1-Year Change

-3340.39%

3-Year Change

-25.4%

5-Year Change

-46.81%

15-Year Change

-46.81%

BIOC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.27%
BIOC annual EBITDA is higher than 43.27% of companies in Healthcare sector

High & Low

All-time High

-$879.00 K

3-Year Low

-$30.24 M
BIOC annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOC next annual earnings announcement has not yet been scheduled

OtherBIOCprofitabilitymetrics:

Annual Revenue

$25.86 M
BIOC annual revenue is $25.86 million

Annual Net Income

-$32.09 M
BIOC annual net profit is -$32.09 million

Annual EBIT

-$31.90 M
BIOC annual earnings before interest & taxes is -$31.90 million

Annual EPS

-$56.70
BIOC annual earnings per share is -$56.70

Quarterly EBITDA

-$3.21 M
+$3.27 M+50.48%

June 30, 2023

Summary

Performance

3-Month Change

+50.48%

1-Year Change

+67.53%

3-Year Change

+48.6%

5-Year Change

+45.5%

BIOC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.29%
BIOC quarterly EBITDA is higher than 55.29% of companies in Healthcare sector

High & Low

All-time High

$3.39 M
BIOC quarterly EBITDA is currently -194.66% below its historical high of $3.39 million

3-Year Low

-$9.89 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCprofitabilitymetrics:

Quarterly Revenue

$589.00 K
BIOC quarterly revenue is $589.00 thousand

Quarterly Net Income

-$3.63 M
BIOC quarterly net profit is -$3.63 million

Quarterly EBIT

-$3.58 M
BIOC quarterly earnings before interest & taxes is -$3.58 million

Quarterly EPS

-$3.50
BIOC quarterly earnings per share is -$3.50

TTM EBITDA

-$28.71 M
+$6.68 M+18.87%

June 30, 2023

Summary

Performance

3-Month Change

+18.87%

1-Year Change

-109.16%

3-Year Change

-13.83%

5-Year Change

-19.05%

BIOC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.2%
BIOC TTM EBITDA is higher than 43.2% of companies in Healthcare sector

High & Low

All-time High

$3.70 M
BIOC TTM EBITDA is currently -876.38% below its historical high of $3.70 million

3-Year Low

-$35.39 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCprofitabilitymetrics:

TTM Revenue

$1.36 M
BIOC TTM revenue is $1.36 million

TTM Net Income

-$30.61 M
BIOC TTM net profit is -$30.61 million

TTM EBIT

-$30.54 M
BIOC TTM earnings before interest & taxes is -$30.54 million

TTM EPS

-$50.90
BIOC TTM earnings per share is -$50.90

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$30.24 M
BIOC annual EBITDA is -$30.24 million

Annual Net Income

-$32.09 M
BIOC annual net profit is -$32.09 million

Annual Interest Expense

$316.00 K
BIOC annual interest expense is $316.00 thousand

Annual Income Tax

-$125.00 K
BIOC annual income tax is -$125.00 thousand

Annual D&A

$1.66 M
BIOC annual depreciation & amortization is $1.66 million

BIOC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3340.4%+67.5%-109.2%
3 y3 years-25.4%+48.6%-13.8%
5 y5 years-46.8%+45.5%-19.1%

BIOC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3340.4%at low-141.4%+67.5%-3226.7%+18.9%
5 y5-year-3340.4%at low-194.7%+67.5%-876.4%+18.9%
alltimeall time-3340.4%at low-194.7%+67.5%-876.4%+18.9%

Biocept EBITDA History

DateAnnualQuarterlyTTM
Jun 2023
-
-$3.21 M(-50.5%)
-$28.71 M(-18.9%)
Mar 2023
-
-$6.48 M(-30.6%)
-$35.39 M(+17.0%)
Dec 2022
-$30.24 M(+3340.4%)
-$9.35 M(-3.3%)
-$30.23 M(+30.2%)
Sep 2022
-
-$9.67 M(-2.3%)
-$23.21 M(+69.1%)
Jun 2022
-
-$9.89 M(+643.5%)
-$13.73 M(+145.8%)
Mar 2022
-
-$1.33 M(-42.9%)
-$5.58 M(+547.2%)
Dec 2021
-$879.00 K(-94.7%)
-$2.33 M(+1200.6%)
-$863.00 K(-123.3%)
Sep 2021
-
-$179.00 K(-89.8%)
$3.70 M(-728.7%)
Jun 2021
-
-$1.75 M(-151.5%)
-$588.20 K(-88.4%)
Mar 2021
-
$3.39 M(+51.9%)
-$5.09 M(-69.3%)
Dec 2020
-$16.57 M(-31.3%)
$2.23 M(-150.0%)
-$16.57 M(-31.7%)
Sep 2020
-
-$4.46 M(-28.5%)
-$24.26 M(-3.8%)
Jun 2020
-
-$6.25 M(-22.8%)
-$25.22 M(-5.0%)
Mar 2020
-
-$8.09 M(+48.3%)
-$26.53 M(+10.0%)
Dec 2019
-$24.11 M(+2.8%)
-$5.46 M(+0.5%)
-$24.11 M(-1.1%)
Sep 2019
-
-$5.43 M(-28.2%)
-$24.37 M(-1.3%)
Jun 2019
-
-$7.56 M(+33.3%)
-$24.70 M(+7.2%)
Mar 2019
-
-$5.67 M(-0.7%)
-$23.03 M(-1.8%)
Dec 2018
-$23.46 M(+13.9%)
-$5.71 M(-0.9%)
-$23.46 M(+1.2%)
Sep 2018
-
-$5.76 M(-2.2%)
-$23.18 M(+0.9%)
Jun 2018
-
-$5.89 M(-3.3%)
-$22.98 M(+2.3%)
Mar 2018
-
-$6.09 M(+12.1%)
-$22.46 M(+9.0%)
DateAnnualQuarterlyTTM
Dec 2017
-$20.60 M(+16.4%)
-$5.44 M(-2.2%)
-$20.60 M(+6.8%)
Sep 2017
-
-$5.56 M(+3.6%)
-$19.29 M(+5.8%)
Jun 2017
-
-$5.37 M(+26.8%)
-$18.23 M(+5.5%)
Mar 2017
-
-$4.23 M(+2.5%)
-$17.28 M(-2.4%)
Dec 2016
-$17.70 M(+9.6%)
-$4.13 M(-8.2%)
-$17.70 M(-1.7%)
Sep 2016
-
-$4.50 M(+1.9%)
-$18.01 M(+1.2%)
Jun 2016
-
-$4.41 M(-5.3%)
-$17.79 M(+3.4%)
Mar 2016
-
-$4.66 M(+5.0%)
-$17.21 M(+6.6%)
Dec 2015
-$16.15 M(+18.5%)
-$4.44 M(+3.5%)
-$16.15 M(+5.1%)
Sep 2015
-
-$4.29 M(+11.9%)
-$15.37 M(+4.3%)
Jun 2015
-
-$3.83 M(+6.4%)
-$14.73 M(+7.1%)
Mar 2015
-
-$3.60 M(-1.6%)
-$13.75 M(+0.9%)
Dec 2014
-$13.62 M(+77.4%)
-$3.66 M(+0.3%)
-$13.62 M(+13.9%)
Sep 2014
-
-$3.65 M(+28.0%)
-$11.96 M(+12.6%)
Jun 2014
-
-$2.85 M(-17.9%)
-$10.62 M(+12.4%)
Mar 2014
-
-$3.47 M(+73.9%)
-$9.45 M(+23.0%)
Dec 2013
-$7.68 M(-20.9%)
-$1.99 M(-13.6%)
-$7.68 M(+2.5%)
Sep 2013
-
-$2.31 M(+37.9%)
-$7.49 M(-0.5%)
Jun 2013
-
-$1.67 M(-1.5%)
-$7.53 M(+28.6%)
Mar 2013
-
-$1.70 M(-6.1%)
-$5.86 M(+40.9%)
Dec 2012
-$9.71 M(-18.5%)
-$1.81 M(-22.9%)
-$4.16 M(+77.1%)
Sep 2012
-
-$2.35 M
-$2.35 M
Dec 2011
-$11.90 M
-
-

FAQ

  • What is Biocept annual EBITDA?
  • What is the all time high annual EBITDA for Biocept?
  • What is Biocept annual EBITDA year-on-year change?
  • What is Biocept quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Biocept?
  • What is Biocept quarterly EBITDA year-on-year change?
  • What is Biocept TTM EBITDA?
  • What is the all time high TTM EBITDA for Biocept?
  • What is Biocept TTM EBITDA year-on-year change?

What is Biocept annual EBITDA?

The current annual EBITDA of BIOC is -$30.24 M

What is the all time high annual EBITDA for Biocept?

Biocept all-time high annual EBITDA is -$879.00 K

What is Biocept annual EBITDA year-on-year change?

Over the past year, BIOC annual EBITDA has changed by -$29.36 M (-3340.39%)

What is Biocept quarterly EBITDA?

The current quarterly EBITDA of BIOC is -$3.21 M

What is the all time high quarterly EBITDA for Biocept?

Biocept all-time high quarterly EBITDA is $3.39 M

What is Biocept quarterly EBITDA year-on-year change?

Over the past year, BIOC quarterly EBITDA has changed by +$6.68 M (+67.53%)

What is Biocept TTM EBITDA?

The current TTM EBITDA of BIOC is -$28.71 M

What is the all time high TTM EBITDA for Biocept?

Biocept all-time high TTM EBITDA is $3.70 M

What is Biocept TTM EBITDA year-on-year change?

Over the past year, BIOC TTM EBITDA has changed by -$14.98 M (-109.16%)